Skip to main content
OpenTrials
Completed

NCT Number: NCT03180203

Postoperative INTELLiVENT-ASV Ventilation

The aim of this study is to investigate whether postoperative ventilation with INTELLiVENT-ASV(adaptive support ventilation) in high risk patients, after cardiothoracic surgery, is as effective, more user-friendly and as safe as compared to the conventional modes of ventilation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ventilators, Mechanical Intensive Care Units Postoperative Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Catharina Hospital

Eindhoven, North Brabant, 5623 EJ, Netherlands

About this study

Recently, Hamilton Medical has introduced the new mechanical ventilation mode "INTELLiVENT-ASV". This is a fully closed ventilation mode that can automatically adjust the ventilation settings based on the measured End tidal CO2 (ETCO2) and the measured saturation (SpO2) in both passive and active ventilated patients. Current literature has shown that this mode is safe to use in patients admitted on the intensive care unit. A pilot study in the Catharina Hospital Eindhoven confirmed that in postoperative low risk patients on the intensive care unit INTELLiVENT-ASV is safe. Compared to continuous mandatory or pressure controlled ventilation with pressure support (conventional mechanical ventilation), INTELLiVENT-ASV is even as effective as conventional mechanical ventilation, with a significantly reduced number of interactions with the ventilator. However, available research about the effectiveness of INTELLiVENT-ASV in postoperative high risk patients is lacking. Also the knowledge about the user-friendliness of the above modes of mechanical ventilation for the users is lacking.

This is a prospective randomized study with a control group and a intervention group of postoperative high risk patients. Through randomization will be determined whether the participant, after surgery, will be mechanically ventilated with INTELLiVENT-ASV and Quickwean or with conventional mechanical ventilation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 18 years of age.
  • Informed consent.
  • Body mass index of <35 kg/m2.
  • Mechanical ventilation after elective cardiothoracic surgery.
  • Admission of the patient after surgery is on the high care unit of the intensive care ward for postoperative mechanical ventilation.

Exclusion criteria

  • Withdrawal of consent
  • Medical history of a pneumonectomy or lobectomy.
  • The patient wit acute respiratory distress syndrome after surgery.
  • The patient with a medical history of COPD Gold 3 or 4.
  • The patient is participating in another postoperative study performed on the intensive care.
  • The patient is, preoperatively determined, eligible for a fast-track postoperative treatment program on the Post Anesthesia Care Unit.

Treatment and study plan

Intellivent-ASV

Device

After ICU admission:

  • The first three hours: only ventilation with INTELLiVENT-ASV with Quickwean.
  • After three hours: Automatic spontaneous breathing trials (SBT) is activated and SBT starts if >10minutes PEEP:<9cmH2O,FiO2:<41%,VT/IBW<5ml/kg and RSB:<106l/l*min.

Settings SBT are MV% 25%,PEEP 5cmH2O.SBT automatically stops if respiratory rate >35b/min or increases >100% since start of SBT, FiO2 >50%, PeTCO2 increases >8mmHg.

Extubation criteria: Leakage <50ml/hr,hemodynamically stable, awake with enough muscle strength and successful SBT >10min.

If during mechanical ventilation the ICU care providers decide that it is necessary for the treatment, they may switch to another ventilation mode or extubate without a SBT.

Conventional modes

Device

After ICU admission:

The first three hours: only ventilation with CMV or PS. If required care providers may change the mode to adaptive support ventilation.

After three hours: manual SBT is required if >10min PS<11cmH2O,PEEP<9cmH2O,FiO2<41%.

Settings SBT are PS 5cmH2O, PEEP 5cmH2O, FiO2 30%. SBT must be stopped if respiratory rate >35b/min or increases >100% since the start of SBT, saturation <92% or the PeTCO2 increases >8mmHg.

Extubation criteria: Leakage <50ml/hr,hemodynamically stable, awake with enough muscle strength and successful SBT >10min.

If during mechanical ventilation the ICU care providers decide that it is necessary for the treatment, they may switch to another ventilation mode or extubate without a SBT.

Primary outcomes

  1. Percentage (%) of mechanical ventilation time in an optimal, acceptable or unacceptable ventilation zone.

    Time frame: During the first 3 hours, since admission on the ICU with the start of the intervention ventilation mode.

    • An optimal zone = Tidal volume (TV) = 4-8 ml/kg of the predicted body weight (PBW) with an EtCO2 = 30-45mmHg, a plateau pressure = <31cmH2O and SpO2 = 93-98%.
    • An acceptable zone = TV = 8-12 ml/kg of PBW with an EtCO2 = 25-30 or 45-50mmHg, a plateau pressure = 31-35 cmH2O and SpO2 = 85-93% or >98%.
    • An unacceptable zone = TV >12 ml/kg of PBW or an EtCO2 = <25 or >50mmHg, plateau pressure >35 cmH2O or SpO2 = <85%.

Secondary outcomes

  1. The percentage (%) of successful extubations.

    Time frame: During the first 24, 48 and 72 hours after extubation

    A successful extubation is an extubation without a new intubation or the use of non-invasive ventilation within 24, 48 or 72 hours.

  2. Postoperative weaning time

    Time frame: 72 hours

    The time from admission on the ICU and a temperature of >35.5°C until extubation.

  3. Workload

    Time frame: 72 hours

    The number of alarms and required interactions between the ventilator and the user during mechanical ventilation on the ICU.

  4. Usability

    Time frame: Up to 1 day after extubation

    A survey with acceptance score (1-10) completed by the care provider at the bedside who treated the patient for the weaning

  5. Patient agitation

    Time frame: Up to 72 hours of mechanical ventilation time

    The number of agitated moments of the patient recognized by the ICU care provider at the bedside.

  6. Administration of sedatives and analgesics

    Time frame: Up to 72 hours of mechanical ventilation time

    The number and dosages of administrations of NSAIDs, opiates, benzodiazepines, clonidine, propofol or haloperidol during mechanical ventilation.

  7. The Richmond Agitation-Sedation Scale (RASS)

    Time frame: Up to 72 hours of mechanical ventilation time

    The RASS for every hour during mechanical ventilation.

  8. Postoperative atelectasis

    Time frame: Up to 48 hours after extubation

    The number of a patients with an atelectasis on the first thoracic x-ray or the thoracic x-ray the following day after surgery.

  9. CO2 levels for postoperative pulmonary shunting

    Time frame: Up to 72 hours of mechanical ventilation time

    The EtCO2/pCO2 ratio during mechanical ventilation.

  10. O2 levels for postoperative pulmonary shunting

    Time frame: Up to 72 hours of mechanical ventilation time

    The pO2/FiO2 ratio during mechanical ventilation.

  11. Reliability of non-invasive oxygen saturation measurement

    Time frame: 72 hours

    The time of mechanical ventilation on the ICU without non-invasive measurement of the oxygen saturation.

Sponsors and collaborators

Lead sponsor

Catharina Ziekenhuis Eindhoven

Other

Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Registry information

Official study title

The Full Closed Loop Ventilation Mode INTELLiVENT-ASV: User-friendly and Effective Mechanical Ventilation in High Risk Postoperative Patient on the Intensive Care Unit

Acronym: POSITiVE

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 8, 2017
Registry last updated
Nov 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.